✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Nanobiotix SA

Common Name
Nanobiotix
Country
France
Sector
Healthcare
Industry
Biotechnology
Employees
108
Ticker
NANO
Exchange
Euronext Paris
Description
Nanobiotix S.A. is a late-stage clinical biotechnology company specializing in physics-based nanomedicines to revolutionize cancer treatment. Headquartered in Paris, France, with offices in the United...

Nanobiotix's Revenues Data

Explore Nanobiotix's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
34,850,089a
€29,643,000
12,080,500a
-€11,609,000
33,268,796a
€30,058,000
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Nanobiotix’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Nanobiotix's 20-F 2025